Estrogen replacement therapy is not a recommended therapy for postmenopausal women with coronary heart disease: a meta-analysis
Journal Title: Clinical and Experimental Obstetrics & Gynecology - Year 2019, Vol 46, Issue 2
Abstract
Aim: This study was to investigate the effect of estrogen replacement therapy (ERT) on clinical outcomes for postmenopausal women with established coronary heart disease (CHD). Materials and Methods: The authors conducted a meta-analysis using 12 eligible studies. The overall odds ratios (OR) or standardized mean difference (SMD) and their corresponding 95% confidence interval (CI) were calculated. Results: For the incidence of adverse events, significant difference was observed in the occurrence rates of CHD death (OR = 1.166, 95% CI: 1.000-1.360, p = 0.050) and death of any cause (OR = 1.221, 95% CI: 1.057-1.410, p = 0.007) in postmenopausal women with CHD between ERT and placebo groups, whereas there was no significant difference (p > 0.05) in the occurrence rates of CHD events, myocardial infarction (MI), revascularization, unstable angina (UA), venous thromboembolic event, stroke/transient ischemic attack, and congestive heart failure between two groups. With respect to the alterations of other clinical outcomes, the SMD for the alteration of TC level was -0.192 (95% CI: -0.346—0.047, p = 0.015), and a significant difference was detected between the two groups, whereas there was no significant difference (p > 0.05) in the alterations of MLD and TG in patients between the two groups. Additionally, patients treated with ERT had lower LDL and higher HDL levels. Conclusion: This meta-analysis suggests that postmenopausal women with CHD receiving ERT are more likely to suffer from CHD death, death of any cause, lower LDL, and higher HDL and TC levels. Therefore, ERT should not be recommended to postmenopausal women with CHD for the secondary prevention of cardiovascular disease (CVD) clinically.
Authors and Affiliations
Y. Zheng, G. Niu, H. Zhang, W. Lu, Z. Liu
Keywords
Related Articles
- EP ID EP620225
- DOI 10.12891/ceog4485.2019
- Views 56
- Downloads 0
Screening for group B hemolytic streptococcal infection in pregnancy in a low-resourced country
Objectives: The objectives of this study conducted in a low-resourced country were to determine the feasibility and acceptability among pregnant women of universal screening for group B streptococcus (GBS), the prevalenc...
The efficacy and safety of intravaginal misoprostol for the induction of labor in patients with obstetrical or medical indication for labor induction
Background: Labor induction is becoming one of the most frequent procedures in maternity hospitals. However, the optimal agent for labor induction has not yet been established. Misoprostol, a prostaglandin E1 analogue, i...
Myoinositol supplementation on intracytoplasmic sperm injection outcome in Japanese infertile polycystic ovarian syndrome women with non-obese less-androgenic phenotype: a prospective controlled observational study
Purpose of Investigation: The objective of this prospective controlled observational study was to evaluate the effect of myoinositol supplementation on intracytoplasmic sperm injection (ICSI) outcome in Japanese infertil...
A novel treatment of severe dysmenorrhea due to adenomyosis: a case series of 3 infertile patients treated with dopamine agonist and in vitro fertilization-embryo transfer resulting in successful pregnancy
Few therapies for adenomyosis are available for infertile patients with reduced ovarian reserve. Previous studies investigating dopamine agonists on endometriosis have reported a reduction of peritoneal endometriosis and...
Predictive value of neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and mean platelet volume for pelvic inflammatory disease
Purpose: The aim of this study was to investigate the efficacies of neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and mean platelet volume (MPV) as early markers in patients with pelvic inflamm...